Across TCGA pan-cancer cohorts, RN7SKP126 RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated RN7SKP126 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher RN7SKP126 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RN7SKP126 expression acts as an unfavorable survival marker, although some lineages such as LUAD show a favorable association.

LUAD and OV are the cancer types where RN7SKP126 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Tertile	All	1.000	0.782	.009	18	view →
OV	OS	Tertile	II,III,IV	0.532	0.846	.017	12	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: RN7SKP126 tumor-vs-normal RNA expression · all RN7SKP126 data types